{
    "clinical_study": {
        "@rank": "73898", 
        "arm_group": [
            {
                "arm_group_label": "Ventricular tachycardia", 
                "description": "Patients with ventricular tachycardia of unknown origin treated with an ICD."
            }, 
            {
                "arm_group_label": "Family members", 
                "description": "Family members (parents, siblings and children) for patients with results showing mutations in the calmodulin genes."
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The aim of this study is to screen a well characterized patient population with ventricular\n      tachycardia  of unknown origin and treated with an implantable cardioverter-defibrillator\n      (ICD) for mutations in the calmodulin genes."
        }, 
        "brief_title": "Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study", 
        "condition": "Ventricular Tachycardia", 
        "condition_browse": {
            "mesh_term": [
                "Arrhythmias, Cardiac", 
                "Tachycardia", 
                "Tachycardia, Ventricular"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with ventricular tachycardia  of unknown origin and treated with an implantable\n      cardioverter-defibrillator (ICD) will be asked to participate in the study. For patients\n      with results showing mutations in the calmodulin genes, family members (parents, siblings\n      and children) will also be asked to participate in the study. For under age patients and\n      relatives who agree to participate, informed consent will also be taken from their\n      custodian."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with ventricular tachycardia of unknown origin that have been treated with\n             an ICD\n\n          -  Signed and dated informed consent\n\n        Exclusion Criteria:\n\n        - Inability to provide informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with ventricular tachycardia of unknown origin and treated with an ICD"
            }
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01947543", 
            "org_study_id": "Protocol no: 2012-11"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 23, 2013", 
        "location": {
            "contact": {
                "last_name": "Peter Linde", 
                "phone": "+46 19 602 10 00"
            }, 
            "facility": {
                "address": {
                    "city": "\u00d6rebro", 
                    "country": "Sweden", 
                    "zip": "70185"
                }, 
                "name": "Department of Cardiology, \u00d6rebro University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Peter Linde", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ole Fr\u00f6bert, MD, PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_groups": "2", 
        "official_title": "Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study", 
        "overall_contact": {
            "email": "ole.frobert@orebroll.se", 
            "last_name": "Ole Fr\u00f6bert", 
            "phone": "+46 19 602 10 00"
        }, 
        "overall_official": {
            "affiliation": "Department of Cardiology, \u00d6rebro University Hospital, \u00d6rebro, Sweden", 
            "last_name": "Ole Fr\u00f6bert, MD, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Mutations in the calmodulin genes", 
            "safety_issue": "No", 
            "time_frame": "1 month."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01947543"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Orebro", 
            "investigator_full_name": "Ole Frobert", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital Orebro", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Orebro", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}